Spanish Red Biotech Pipeline

IRYCIS

PREVEMAMA

Type: Others
Therapeutic area: Cancer
Indication: APP for prevention of breast cancer
Phase: 5Ready to Market, 4Register, 3Clinical validation, 2Preclinical Validation, 1R+D
Studies location: